| Primary Identifier | MGI:6272337 | Allele Type | Transgenic |
| Attribute String | Constitutively active, Inserted expressed sequence | Gene | Tg(Tyr-Ctnnb1/EGFP)#Lru |
| Strain of Origin | Not Specified | Is Recombinase | false |
| Is Wild Type | false |
| molecularNote | The mouse tyrosinase (Tyr) gene enhancer was fused to the Tyr promoter region to produce a 6.1-kb regulatory element driving the expression of a cDNA encoding a stabilized form of beta-catenin in which Ser33, Ser37, Ser45, and Thr41 were replaced by alanines (A33, A37, A41, A45). A nuclear localization signal (nls) and EGFP sequences were fused in frame to the 3' end of the mutated beta-catenin cDNA. An SV40 small T-antigen splice site and polyadenylation sequence were added to the 3' end of the construct to produce Tyr::beta-cat-mut-nls-egfp (bcatsta). This expression vector produces a constitutively activated nuclear form of the protein that is comparable in its activity to the mutated form of beta-catenin found in melanomas and other cancers. The transgene was confirmed to be specifically expressed in cells of the melanocyte lineage. Two independent lines (lines 1 and 2) were generated, both presenting a hypopigmented coat color phenotype. The level of transgene expression in melanocytes cultured from newborn skin was ~10% and 5% of that of the endogenous protein in lines 1 and 2, respectively. The lines are pooled, as denoted by the pound (#) sign. |
